home.social

#cancerresearch — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cancerresearch, aggregated by home.social.

  1. Oncotelic's AI-driven PDAOAI platform is revolutionizing cancer research by analyzing 20M+ scientific abstracts to extract insights from complex datasets. #AI #CancerResearch

  2. Oncotelic's AI-driven PDAOAI platform is revolutionizing cancer research by analyzing 20M+ scientific abstracts to extract insights from complex datasets. #AI #CancerResearch

  3. Oncotelic's AI-driven PDAOAI platform is revolutionizing cancer research by analyzing 20M+ scientific abstracts to extract insights from complex datasets. #AI #CancerResearch

  4. Alliance Pavers partners with M/I Homes on 2026 Pelotonia initiative to support cancer research. Construction of the Pelotonia Home in Orlando begins May 6. #CancerResearch #Community

  5. Alliance Pavers partners with M/I Homes on 2026 Pelotonia initiative to support cancer research. Construction of the Pelotonia Home in Orlando begins May 6. #CancerResearch #Community

  6. Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update

    Competing interests A.C. has received speaking fees from AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Novo Nordisk, Sanofi and Menarini; research…
    #Europe #EU #Biomedicine #CancerResearch #EuropeanUnion #general #InfectiousDiseases #MetabolicDiseases #MolecularMedicine #Neurosciences #Obesity
    europesays.com/europe/42284/

  7. Mel Gibson’s Joe Rogan spot helped ivermectin cancer prescriptions spike

    NEWYou can now listen to Fox News articles! Prescriptions for an antiparasitic drug spiked for cancer patients after…
    #NewsBeep #News #Celebrities #Alternativemedicine #CA #Canada #cancer #CancerResearch #Entertainment #Health #medications
    newsbeep.com/ca/667794/

  8. Alfa Cytology launches groundbreaking PrimePDX platform, revolutionizing preclinical cancer research by enabling more accurate immune response modeling and treatment evaluation in immunotherapy studies. A major leap forward for researchers worldwide. #CancerResearch #Immunotherapy

  9. Alfa Cytology launches groundbreaking PrimePDX platform, revolutionizing preclinical cancer research by enabling more accurate immune response modeling and treatment evaluation in immunotherapy studies. A major leap forward for researchers worldwide. #CancerResearch #Immunotherapy

  10. Northwestern researchers unveil rapid blood test to assess brain cancer treatment effectiveness, potentially transforming patient care and clinical decision-making. Groundbreaking diagnostic tool offers immediate insights into therapy response. #MedicalInnovation #CancerResearch

  11. Northwestern researchers unveil rapid blood test to assess brain cancer treatment effectiveness, potentially transforming patient care and clinical decision-making. Groundbreaking diagnostic tool offers immediate insights into therapy response. #MedicalInnovation #CancerResearch

  12. Oncotelic Therapeutics reveals groundbreaking biomarker study analyzing cancer microenvironment across 7,000 patient samples, uncovering critical insights into personalized treatment strategies. #CancerResearch #Oncology

  13. Oncotelic Therapeutics reveals groundbreaking biomarker study analyzing cancer microenvironment across 7,000 patient samples, uncovering critical insights into personalized treatment strategies. #CancerResearch #Oncology

  14. TransCode Therapeutics and Quantum Leap launch collaborative clinical trial targeting colorectal cancer minimal residual disease, evaluating innovative RNA therapeutic TTX-MC138 #CancerResearch #Oncology

  15. TransCode Therapeutics and Quantum Leap launch collaborative clinical trial targeting colorectal cancer minimal residual disease, evaluating innovative RNA therapeutic TTX-MC138 #CancerResearch #Oncology

  16. Washington University researchers discover critical timing factor in brain cancer treatment, potentially improving patient outcomes through strategic chemotherapy administration. #CancerResearch #MedicalInnovation

  17. Washington University researchers discover critical timing factor in brain cancer treatment, potentially improving patient outcomes through strategic chemotherapy administration. #CancerResearch #MedicalInnovation

  18. Young Women Face Rising Tide of Aggressive Breast Cancers

    Younger women in the US are diagnosed with more aggressive breast cancers. Find out why and what this means for them.

    #BreastCancer, #YoungWomen, #CancerResearch, #HealthNews, #USHealth

    newsletter.tf/young-women-unde

  19. Terry Fox: Canada’s Marathon of Hope

    In 1980, Terry Fox, after losing his leg to cancer, began his "Marathon of Hope"🏃‍♂️, to run across Canada for cancer research. He ran 42 km a day for 143 days! Sadly, his journey was cut short, but his courage continues to inspire. The annual Terry Fox Run keeps his dream alive for cancer research and shows the power of the human spirit. ❤️ 🇨🇦
    #TerryFox #MarathonofHope #CancerResearch #Canada 🇨🇦

    en.wikipedia.org/wiki/Terry_Fox

  20. Terry Fox: Canada’s Marathon of Hope

    In 1980, Terry Fox, after losing his leg to cancer, began his "Marathon of Hope"🏃‍♂️, to run across Canada for cancer research. He ran 42 km a day for 143 days! Sadly, his journey was cut short, but his courage continues to inspire. The annual Terry Fox Run keeps his dream alive for cancer research and shows the power of the human spirit. ❤️ 🇨🇦
    🇨🇦

    en.wikipedia.org/wiki/Terry_Fox

  21. Terry Fox: Canada’s Marathon of Hope

    In 1980, Terry Fox, after losing his leg to cancer, began his "Marathon of Hope"🏃‍♂️, to run across Canada for cancer research. He ran 42 km a day for 143 days! Sadly, his journey was cut short, but his courage continues to inspire. The annual Terry Fox Run keeps his dream alive for cancer research and shows the power of the human spirit. ❤️ 🇨🇦
    #TerryFox #MarathonofHope #CancerResearch #Canada 🇨🇦

    en.wikipedia.org/wiki/Terry_Fox

  22. "#Breastcancer diagnoses are increasing at a rate of 1% per year for all women, and at 1.4% per year for women under 50, according to the #American #Cancer Society.

    Fortunately, new technologies are making diagnosis and treatment more effective than ever before, improving breast cancer survival rates even as cases are climbing. Today, the five-year survival rate for all breast #cancers is 91% — and that rate rises to 99% when breast cancer is caught in the earliest stages.

    And that’s not the only good news. Breast #cancerresearch is constantly evolving, and #Sharsheret, the #Jewish breast cancer and ovarian cancer organization, is committed to sharing information about the latest cancer #research."

    jta.org/2026/05/06/health/5-th

  23. "#Breastcancer diagnoses are increasing at a rate of 1% per year for all women, and at 1.4% per year for women under 50, according to the #American #Cancer Society.

    Fortunately, new technologies are making diagnosis and treatment more effective than ever before, improving breast cancer survival rates even as cases are climbing. Today, the five-year survival rate for all breast #cancers is 91% — and that rate rises to 99% when breast cancer is caught in the earliest stages.

    And that’s not the only good news. Breast #cancerresearch is constantly evolving, and #Sharsheret, the #Jewish breast cancer and ovarian cancer organization, is committed to sharing information about the latest cancer #research."

    jta.org/2026/05/06/health/5-th

  24. "#Breastcancer diagnoses are increasing at a rate of 1% per year for all women, and at 1.4% per year for women under 50, according to the #American #Cancer Society.

    Fortunately, new technologies are making diagnosis and treatment more effective than ever before, improving breast cancer survival rates even as cases are climbing. Today, the five-year survival rate for all breast #cancers is 91% — and that rate rises to 99% when breast cancer is caught in the earliest stages.

    And that’s not the only good news. Breast #cancerresearch is constantly evolving, and #Sharsheret, the #Jewish breast cancer and ovarian cancer organization, is committed to sharing information about the latest cancer #research."

    jta.org/2026/05/06/health/5-th

  25. "#Breastcancer diagnoses are increasing at a rate of 1% per year for all women, and at 1.4% per year for women under 50, according to the #American #Cancer Society.

    Fortunately, new technologies are making diagnosis and treatment more effective than ever before, improving breast cancer survival rates even as cases are climbing. Today, the five-year survival rate for all breast #cancers is 91% — and that rate rises to 99% when breast cancer is caught in the earliest stages.

    And that’s not the only good news. Breast #cancerresearch is constantly evolving, and #Sharsheret, the #Jewish breast cancer and ovarian cancer organization, is committed to sharing information about the latest cancer #research."

    jta.org/2026/05/06/health/5-th

  26. "#Breastcancer diagnoses are increasing at a rate of 1% per year for all women, and at 1.4% per year for women under 50, according to the #American #Cancer Society.

    Fortunately, new technologies are making diagnosis and treatment more effective than ever before, improving breast cancer survival rates even as cases are climbing. Today, the five-year survival rate for all breast #cancers is 91% — and that rate rises to 99% when breast cancer is caught in the earliest stages.

    And that’s not the only good news. Breast #cancerresearch is constantly evolving, and #Sharsheret, the #Jewish breast cancer and ovarian cancer organization, is committed to sharing information about the latest cancer #research."

    jta.org/2026/05/06/health/5-th

  27. 🧠 Neuro Oncology - Apr 2026

    • BIOMEDE trial for DIPG halted due to futility
    • Combination therapies prolong survival in diffuse midline glioma
    • Two immune landscapes in BCBM predict patient survival
    • Microglial responses to glioblastoma invasion found to be biphasic

    pir.sh/nKzaEkE1Jp

    #NeuroOncology #CancerResearch

  28. Erstmals hat die FDA einen PROTAC zugelassen. Veppanu vernichtet das Brustkrebsprotein in der Zelle statt es zu blockieren und verdoppelt für Risikopatientinnen die stabile Zeit.

    denkstrom.org/artikel/veppanu-

    #Medizin #Health #CancerResearch #GoodNews #GuteNachrichten #News #Press #Nachrichten #Fediverse #Mastodon #Deutschland

  29. Erstmals hat die FDA einen PROTAC zugelassen. Veppanu vernichtet das Brustkrebsprotein in der Zelle statt es zu blockieren und verdoppelt für Risikopatientinnen die stabile Zeit.

    denkstrom.org/artikel/veppanu-

    #Medizin #Health #CancerResearch #GoodNews #GuteNachrichten #News #Press #Nachrichten #Fediverse #Mastodon #Deutschland

  30. Erstmals hat die FDA einen PROTAC zugelassen. Veppanu vernichtet das Brustkrebsprotein in der Zelle statt es zu blockieren und verdoppelt für Risikopatientinnen die stabile Zeit.

    denkstrom.org/artikel/veppanu-

    #Medizin #Health #CancerResearch #GoodNews #GuteNachrichten #News #Press #Nachrichten #Fediverse #Mastodon #Deutschland

  31. The body’s most mysterious organ may play a key role in longevity and cancer

    For decades, a mysterious, two-lobed organ nestled behind the breastbone has been overlooked by most physicians, thought to…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #cancer #cancerimmunotherapy #CancerResearch
    newsbeep.com/us/622214/